Takeda Seeks To Double Foreign OTC Business To $38 Million By 2017
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical seeks to double overseas sales of over-the-counter drugs over the next three years to help make up for a contracting market in a Japan of fewer buyers and falling prices.